Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
- Friday, June 19, 2020, 7:04
- Finance
- Add a comment
SUZHOU, China, June 19, 2020 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today…
About the Author
adminasapcorp has written 41789 stories on this site.